← Leaderboards
Mei Rosemary Fu
New York University
$916,367
Attributed
$1,380,516
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $356.4K · FY2011–18$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,380,516 · 3
By mechanism
R01$674,413 · 1
R21$452,218 · 1
P60$253,885 · 1
Top collaborators
- Yao Wang3 shared
- Mariano J Rey2 shared
Most similar at New York University
Same institution · by research overlap
- Dora Angelaki$47,761,775
- Shulamite S Huang$901,818
- Michael S Landy$9,726,022
- Tomoko Kitago$244,231
- Adam Buchwald$3,558,231
Others in their field
Top investigators on “Limb Structure”
- Walter John Curran · Thomas Jefferson University$26,641,549
- Cynthia Casson Morton · Dana-Farber Cancer Institute$24,273,260
- Richard A Andersen · California Institute Of Technology$20,589,258
- Scott L Delp · Stanford University$19,149,477
- Clifford J Tabin · Harvard University$14,676,472
- Eiman Abdel-Azim · Harvard Medical School$12,679,260
Research focus
Limb StructureLiquid SubstanceLymphedemaAdverse EffectsAffectSymptomsDistressLymphMalignant Breast NeoplasmCancer SurvivorSwellingQuality Of LifeBaseSamplingOperative Surgical ProceduresPreventionLymphaticMalignant NeoplasmsInterstitialClinical PracticeInfectionInflammationBreast Cancer TreatmentEducational Intervention
Grant awards (7)
SCH: EXP: Improving early detection and intervention of lymphedema$216,636
R01 · FY2018 · CA
SCH: EXP: Improving early detection and intervention of lymphedema$227,835
R01 · FY2017 · CA
SCH: EXP: Improving early detection and intervention of lymphedema$229,942
R01 · FY2016 · CA
Lymphedema Risk Reduction for Chinese Breast Cancer Survivors$19,423
P60 · FY2013 · MD · contact PI
Lymphedema Risk Reduction for Chinese Breast Cancer Survivors$234,462
P60 · FY2012 · MD · contact PI
Proinflammatory Biomarkers and Post-Breast CancerLymphedema$121,986
R21 · FY2012 · NR · contact PI
Proinflammatory Biomarkers and Post-Breast CancerLymphedema$330,232
R21 · FY2011 · NR · contact PI